Transcriptome analysis of human primary endothelial cells (HUVEC) from umbilical cords of gestational diabetic mothers reveals candidate sites for an epigenetic modulation of specific gene expression

Genomics

Volumn 103, Issue 5-6, 2014, Pages 337-348

  Ambra, R ^a   Manca, S ^a   Palumbo, M C ^a,b   Leoni, G ^a   Natarelli, L ^a   De Marco, A ^c   Consoli, A ^c   Pandolfi, A ^c   Virgili, F ^a  

^a ISTITUTO NAZIONALE DELLA NUTRIZIONE   (Italy)

^b CNR   (Italy)

^c UNIVERSITY OF CHIETI   (Italy)

Author keywords

Epigenetic; Gestational diabetes; HUVEC; Hyperglycemia; Transcriptome

Indexed keywords

FIBROBLAST GROWTH FACTOR 2; INSULIN; INTERCELLULAR ADHESION MOLECULE 1; PLATELET DERIVED GROWTH FACTOR BETA RECEPTOR; TRANSCRIPTOME; TRANSFORMING GROWTH FACTOR BETA2; PRIMER DNA;

ARTICLE; CARD11 GENE; CCND2 GENE; CDKN2B GENE; CELL CYCLE; COL1A1 GENE; COL3A1 GENE; CONTROLLED STUDY; DDR2 GENE; DNA METHYLATION; EPIGENETICS; EXTRACELLULAR MATRIX; FBN1 GENE; FBN2 GENE; FEMALE; FETUS; FGF2 GENE; FN1 GENE; FST GENE; FSTL3 GENE; GENE; GENE EXPRESSION; GENE ONTOLOGY; HUMAN; HUMAN CELL; HYPERGLYCEMIA; ICAM1 GENE; LIPG GENE; MICROARRAY ANALYSIS; MOTHER; NEWBORN; NUCLEOTIDE SEQUENCE; PDGFBR GENE; PREGNANCY DIABETES MELLITUS; PRIORITY JOURNAL; PROMOTER REGION; TGFB2 GENE; TRANSCRIPTOMICS; UMBILICAL VEIN ENDOTHELIAL CELL; UNINDEXED SEQUENCE; ADULT; CASE CONTROL STUDY; CELL CULTURE; DNA MICROARRAY; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORK; GENETIC EPIGENESIS; GENETICS; METABOLISM; MOLECULAR GENETICS; PATHOLOGY; PREGNANCY; UMBILICAL CORD;

ADULT; BASE SEQUENCE; CASE-CONTROL STUDIES; CELLS, CULTURED; DIABETES, GESTATIONAL; DNA METHYLATION; DNA PRIMERS; EPIGENESIS, GENETIC; FEMALE; GENE EXPRESSION PROFILING; GENE REGULATORY NETWORKS; HUMAN UMBILICAL VEIN ENDOTHELIAL CELLS; HUMANS; MOLECULAR SEQUENCE ANNOTATION; OLIGONUCLEOTIDE ARRAY SEQUENCE ANALYSIS; PREGNANCY; PROMOTER REGIONS, GENETIC; TRANSCRIPTOME; UMBILICAL CORD;

EID: 84902124010     PISSN: 08887543     EISSN: 10898646     Source Type: Journal    
DOI: 10.1016/j.ygeno.2014.03.003     Document Type: Article

References (57)

1. Baumgartner-Parzer S.M., Wagner L., Pettermann M., Grillari J., Gessl A., Waldhausl W. High-glucose-triggered apoptosis in cultured endothelial cells. Diabetes 1995, 44:1323-1327.
2. Koh G.C., Peacock S.J., van der Poll T., Wiersinga W.J. The impact of diabetes on the pathogenesis of sepsis. Eur. J. Clin. Microbiol. Infect. Dis. 2012, 31:379-388.
3. Nielson C., Lange T. Blood glucose and heart failure in nondiabetic patients. Diabetes Care 2005, 28:607-611.
4. Buchanan T.A., Xiang A.H. Gestational diabetes mellitus. J. Clin. Invest. 2005, 115:485-491.
5. Wendland E.M., Torloni M.R., Falavigna M., Trujillo J., Dode M.A., Campos M.A., Duncan B.B., Schmidt M.I. Gestational diabetes and pregnancy outcomes - a systematic review of the World Health Organization (WHO) and the International Association of Diabetes in Pregnancy Study Groups (IADPSG) diagnostic criteria. BMC Pregnancy Childbirth 2012, 12.
6. Lambrinoudaki I., Vlachou S.A., Creatsas G. Genetics in gestational diabetes mellitus: association with incidence, severity, pregnancy outcome and response to treatment. Curr. Diab. Rev. 2010, 6:393-399.
7. Robitaille J., Grant A.M. The genetics of gestational diabetes mellitus: evidence for relationship with type 2 diabetes mellitus. Genet. Med. 2008, 10:240-250.
8. Cooper M.E., El-Osta A. Epigenetics: mechanisms and implications for diabetic complications. Circ. Res. 2010, 107:1403-1413.
9. Federici M., Pandolfi A., De Filippis E.A., Pellegrini G., Menghini R., Lauro D., Cardellini M., Romano M., Sesti G., Lauro R., Consoli A. G972R IRS-1 variant impairs insulin regulation of endothelial nitric oxide synthase in cultured human endothelial cells. Circulation 2004, 109:399-405.
10. Edgell C.J.S., McDonald C.C., Graham J.B. Permanent cell line expressing human factor VIII-related antigen established by hybridization. Proc. Natl. Acad. Sci. U. S. A. 1983, 80:3734-3737.
11. Qiu W., Lee M.L.T., Whitmore G.A. Sample size and power calculation in microarray studies. R package version 1.26.0 2006.
12. Oakes C.C., Salle S., Trasler J.M., Robaire B. Restriction digestion and real-time PCR (qAMP) DNA methylation 2009, 271-280. Humana Press. J. Tost (Ed.).
13. Edgar R., Domrachev M., Lash A.E. Gene Expression Omnibus: NCBI gene expression and hybridization array data repository. Nucleic Acids Res. 2002, 30:207-210.
14. Gao J., Ade A.S., Tarcea V.G., Weymouth T.E., Mirel B.R., Jagadish H.V., States D.J. Integrating and annotating the interactome using the MiMI plugin for cytoscape. Bioinformatics 2009, 25:137-138.
15. Chmurzynska A. Fetal programming: link between early nutrition, DNA methylation, and complex diseases. Nutr. Rev. 2010, 68:87-98.
16. El-Osta A. Glycemic memory. Curr. Opin. Lipidol. 2012, 23:24-29.
17. Hiden U., Glitzner E., Hartmann M., Desoye G. Insulin and the IGF system in the human placenta of normal and diabetic pregnancies. J. Anat. 2009, 215:60-68.
18. Cwyfan Hughes S.C., Johnson M.R., Heinrich G., Holly J.M.P. Could abnormalities in insulin-like growth factors and their binding proteins during pregnancy result in gestational diabetes?. J. Endocrinol. 1995, 147:517-524.
19. Colomiere M., Permezel M., Riley C., Desoye G., Lappas M. Defective insulin signaling in placenta from pregnancies complicated by gestational diabetes mellitus. Eur. J. Endocrinol. 2009, 160:567-578.
20. Gosmanov A.R., Stentz F.B., Kitabchi A.E. De novo emergence of insulin-stimulated glucose uptake in human aortic endothelial cells incubated with high glucose. Am. J. Physiol. Endocrinol. Metab. 2006, 290:E516-E522.
21. Cheng Z., Tseng Y., White M.F. Insulin signaling meets mitochondria in metabolism. Trends Endocrinol. Metab. 2010, 21:589-598.
22. Orimo M., Minamino T., Miyauchi H., Tateno K., Okada S., Komuro I. Protective role of SIRT1 in diabetic vascular dysfunction. Arterioscler. Thromb. Vasc. Biol. 2009, 29:889-894.
23. Roos S., Jansson N., Palmberg I., Säljö K., Powell T.L., Jansson T. Mammalian target of rapamycin in the human placenta regulates leucine transport and is down-regulated in restricted fetal growth. J. Physiol. 2007, 582:449-459.
24. Li J., DeFea K., Roth R.A. Modulation of insulin receptor substrate-1 tyrosine phosphorylation by an Akt/phosphatidylinositol 3-kinase pathway. J. Biol. Chem. 1999, 274:9351-9356.
25. Di Camillo B., Sanavia T., Iori E., Bronte V., Roncaglia E., Maran A., Avogaro A., Toffolo G., Cobelli C. The transcriptional response in human umbilical vein endothelial cells exposed to insulin: a dynamic gene expression approach. PLoS One 2010, 5:e14390.
26. Wang R.H., Kim H.S., Xiao C., Xu X., Gavrilova O., Deng C.X. Hepatic Sirt1 deficiency in mice impairs mTorc2/Akt signaling and results in hyperglycemia, oxidative damage, and insulin resistance. J. Clin. Invest. 2011, 121:4477-4490.
27. Calera M.R., Martinez C., Liu H., El Jack A.K., Birnbaum M.J., Pilch P.F. Insulin increases the association of Akt-2 with Glut4-containing vesicles. J. Biol. Chem. 1998, 273:7201-7204.
28. Pardali E., Goumans M.J., ten Dijke P. Signaling by members of the TGF-beta family in vascular morphogenesis and disease. Trends Cell Biol. 2010, 20:556-567.
29. Kubiczkova L., Sedlarikova L., Hajek R., Sevcikova S. TGF-beta - an excellent servant but a bad master. J. Transl. Med. 2012, 10:183.
30. Monteleone G., Mann J., Monteleone I., Vavassori P., Bremner R., Fantini M., Del Vecchio Blanco G., Tersigni R., Alessandroni L., Mann D., Pallone F., MacDonald T.T. A failure of transforming growth factor-beta1 negative regulation maintains sustained NF-kappaB activation in gut inflammation. J. Biol. Chem. 2004, 279:3925-3932.
31. Vidro E.K., Gee S., Unda R., Ma J.X., Tsin A. Glucose and TGFβ2 modulate the viability of cultured human retinal pericytes and their VEGF release. Curr. Eye Res. 2008, 33:984-993.
32. Malipiero U., Holler M., Werner U., Fontana A. Sequence analysis of the promoter region of the glioblastoma derived T cell suppressor factor/transforming growth factor (TGF)-β2 gene reveals striking differences to the TGF-β1 and -β3 genes. Biochem. Biophys. Res. Commun. 1990, 171:1145-1151.
33. Lu T., Burdelya L.G., Swiatkowski S.M., Boiko A.D., Howe P.H., Stark G.R., Gudkov A.V. Secreted transforming growth factor β2 activates NF-κB, blocks apoptosis, and is essential for the survival of some tumor cells. Proc. Natl. Acad. Sci. U. S. A. 2004, 101:7112-7117.
34. El-Osta A., Brasacchio D., Yao D., Pocai A., Jones P.L., Roeder R.G., Cooper M.E., Brownlee M. Transient high glucose causes persistent epigenetic changes and altered gene expression during subsequent normoglycemia. J. Exp. Med. 2008, 205:2409-2417.
35. Ait-Ali D., Turquier V., Tanguy Y., Thouënnon E., Ghzili H., Mounien L., Derambure C., Jégou S., Salier J.P., Vaudry H., Eiden L.E., Anouar Y. Tumor necrosis factor (TNF)-α persistently activates nuclear factor-κB signaling through the type 2 TNF receptor in chromaffin cells: implications for long-term regulation of neuropeptide gene expression in inflammation. Endocrinology 2008, 149:2840-2852.
36. Rifkin D.B. Latent transforming growth factor-β (TGF-β) binding proteins: orchestrators of TGF-β availability. J. Biol. Chem. 2005, 280:7409-7412.
37. Ito H., Duxbury M., Benoit E., Farivar R.S., Gardner-Thorpe J., Zinner M.J., Ashley S.W., Whang E.E. Fibronectin-induced COX-2 mediates MMP-2 expression and invasiveness of rhabdomyosarcoma. Biochem. Biophys. Res. Commun. 2004, 318:594-600.
38. Cagliero E., Maiello M., Boeri D., Roy S., Lorenzi M. Increased expression of basement membrane components in human endothelial cells cultured in high glucose. J. Clin. Invest. 1988, 82:735-738.
39. Roy S., Sala R., Cagliero E., Lorenzi M. Overexpression of fibronectin induced by diabetes or high glucose: phenomenon with a memory. Proc. Natl. Acad. Sci. U. S. A. 1990, 87:404-408.
40. Cagliero E., Forsberg H., Sala R., Lorenzi M., Eriksson U.J. Maternal diabetes induces increased expression of extracellular matrix components in rat embryos. Diabetes 1993, 42:975-980.
41. Chen S., Feng B., George B., Chakrabarti R., Chen M., Chakrabarti S. Transcriptional coactivator p300 regulates glucose-induced gene expression in endothelial cells. Am. J. Physiol. Endocrinol. Metab. 2010, 298:E127-E137.
42. Brown M.L., Bonomi L., Ungerleider N., Zina J., Kimura F., Mukherjee A., Sidis Y., Schneyer A. Follistatin and follistatin like-3 differentially regulate adiposity and glucose homeostasis. Obesity (Silver Spring) 2011, 19:1940-1949.
43. Hu D., Tian T., Guo J., Wang H., Chen D., Dong M. Decreased maternal and placental concentrations of follistatin-like 3 in gestational diabetes. Clin. Chim. Acta 2012, 413:533-536.
44. Cortese R., Hartmann O., Berlin K., Eckhardt F. Correlative gene expression and DNA methylation profiling in lung development nominate new biomarkers in lung cancer. Int. J. Biochem. Cell Biol. 2008, 40:1494-1508.
45. Gaikwad A.B., Gupta J., Tikoo K. Epigenetic changes and alteration of Fbn1and Col3A1gene expression under hyperglycaemic and hyperinsulinaemic conditions. Biochem. J. 2010, 432:333-341.
46. Vogel W., Gish G.D., Alves F., Pawson T. The discoidin domain receptor tyrosine kinases are activated by collagen. Mol. Cell 1997, 1:13-23.
47. Ferri N., Carragher N.O., Raines E.W. Role of discoidin domain receptors 1 and 2 in human smooth muscle cell-mediated collagen remodeling: potential implications in atherosclerosis and lymphangioleiomyomatosis. Am. J. Pathol. 2004, 164:1575-1585.
48. Makino K., Jinnin M., Aoi J., Hirano A., Kajihara I., Makino T., Sakai K., Fukushima S., Inoue Y., Ihn H. Discoidin domain receptor 2-microRNA 196a-mediated negative feedback against excess type I collagen expression is impaired in scleroderma dermal fibroblasts. J. Invest. Dermatol. 2012, 133:110-119.
49. Grissa O., Yessoufou A., Mrisak I., Hichami A., Amoussou-Guenou D., Grissa A., Djrolo F., Moutairou K., Miled A., Khairi H., Zaouali M., Bougmiza I., Zbidi A., Tabka Z., Khan N.A. Growth factor concentrations and their placental mRNA expression are modulated in gestational diabetes mellitus: possible interactions with macrosomia. BMC Pregnancy Childbirth 2010, 10.
50. Lygnos M.C., Pappa K.I., Papadaki H.A., Relakis C., Koumantakis E., Anagnou N.P., Eliopoulos G.D. Changes in maternal plasma levels of VEGF, bFGF, TGF-β1, ET-1 and sKL during uncomplicated pregnancy, hypertensive pregnancy and gestational diabetes. In Vivo 2006, 20:157-164.
51. Morss A.S., Edelman E.R. Glucose modulates basement membrane fibroblast growth factor-2 via alterations in endothelial cell permeability. J. Biol. Chem. 2007, 282:14635-14644.
52. Inaba T., Ishibashi S., Gotoda T., Kawamura M., Morino N., Nojima Y., Kawakami M., Yazaki Y., Yamada N. Enhanced expression of platelet-derived growth factor-β receptor by high glucose: involvement of platelet-derived growth factor in diabetic angiopathy. Diabetes 1996, 45:507-512.
53. Shimizu H., Nakagawa Y., Murakami C., Aoki N., Kim-Mitsuyama S., Miyazaki H. Protein tyrosine phosphatase PTPεM negatively regulates PDGF β-receptor signaling induced by high glucose and PDGF in vascular smooth muscle cells. Am. J. Physiol. Cell Physiol. 2010, 299:C1144-C1152.
54. Hewitt K.J., Shamis Y., Knight E., Smith A., Maione A., Alt-Holland A., Sheridan S.D., Haggarty S.J., Garlick J.A. PDGFRβ expression and function in fibroblasts derived from pluripotent cells is linked to DNA demethylation. J. Cell Sci. 2012, 125:2276-2287.
55. Kusy S., Larsen C.J., Roche J. p14ARF, p15INK4b and p16INK4a methylation status in chronic myelogenous leukemia. Leuk. Lymphoma 2004, 45:1989-1994.
56. Hribal M.L., Presta I., Procopio T., Marini M.A., Stančáková A., Kuusisto J., Andreozzi F., Hammarstedt A., Jansson P.A., Grarup N., Hansen T., Walker M., Stefan N., Fritsche A., Häring H.U., Pedersen O., Smith U., Laakso M., Sesti G. Glucose tolerance, insulin sensitivity and insulin release in European non-diabetic carriers of a polymorphism upstream of CDKN2A and CDKN2B. Diabetologia 2011, 54:795-802.
57. Chen Y.H., Guh J.Y., Chuang T.D., Chen H.C., Chiou S.J., Huang J.S., Yang Y.L., Chuang L.Y. High glucose decreases endothelial cell proliferation via the extracellular signal regulated kinase/p15INK4b pathway. Arch. Biochem. Biophys. 2007, 465:164-171.